Rani Therapeutics Holdings Future Growth
Future criteria checks 0/6
Rani Therapeutics Holdings is forecast to grow earnings and revenue by 6.5% and 64.7% per annum respectively while EPS is expected to grow by 10.8% per annum.
Key information
6.5%
Earnings growth rate
10.8%
EPS growth rate
| Pharmaceuticals earnings growth | 23.6% |
| Revenue growth rate | 64.7% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 26 Mar 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 14 | -32 | N/A | N/A | 4 |
| 12/31/2025 | N/A | -33 | N/A | N/A | 6 |
| 12/31/2024 | N/A | -29 | N/A | N/A | 7 |
| 12/31/2023 | N/A | -34 | -52 | -51 | N/A |
| 9/30/2023 | N/A | -36 | -55 | -53 | N/A |
| 6/30/2023 | N/A | -34 | -53 | -51 | N/A |
| 3/31/2023 | N/A | -33 | -51 | -49 | N/A |
| 12/31/2022 | N/A | -31 | -48 | -47 | N/A |
| 9/30/2022 | N/A | -27 | -45 | -43 | N/A |
| 6/30/2022 | N/A | -22 | -43 | -42 | N/A |
| 3/31/2022 | 2 | -15 | -38 | -38 | N/A |
| 12/31/2021 | 3 | -8 | -33 | -32 | N/A |
| 9/30/2021 | 3 | -3 | -28 | -27 | N/A |
| 6/30/2021 | 3 | N/A | -16 | -16 | N/A |
| 3/31/2021 | 1 | 5 | -13 | -13 | N/A |
| 12/31/2020 | 0 | N/A | -16 | -15 | N/A |
| 12/31/2019 | 1 | -27 | -28 | -26 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RANI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: RANI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: RANI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: RANI is forecast to have no revenue next year.
High Growth Revenue: RANI is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if RANI's Return on Equity is forecast to be high in 3 years time